Hints and tips:
Related Special Reports
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...The US Food and Drug Administration recently approved the first-ever drug designed specifically for the most common liver disease, metabolic dysfunction-associated steatohepatitis or mash, developed by Madrigal...
...Roche has cut a fifth of its drug pipeline in six months, shedding prospective cancer and neurology treatments as the Swiss company seeks to revitalise its business under new chief executive Thomas Schinecker...
...The rush to secure manufacturing capacity comes as Wegovy and Mounjaro, which is also commonly prescribed off-label for weight loss, are in short supply, according to the US Food and Drug Administration....
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Soon after Mexico’s president took office in 2018, agents of the US Drug Enforcement Administration knew their job was about to become a lot more difficult....
...Novo Nordisk’s Wegovy medication, which this month received US Food and Drug Administration approval to help reduce heart attack and stroke risk in patients with a history of cardiovascular problems, can...
...to the changes of acting like “rentier” capitalists defending broken markets....
...It is also one of the largest sources of illegal migration to the US as its citizens flee gang violence and one of the highest poverty rates in Central America....
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...Ecuador has reached a deal with the IMF worth about $4bn in financing over four years, as the South American country seeks to loosen its constrained finances amid a crackdown on drug traffickers....
...AstraZeneca has reported successful trial results for one of its top cancer drugs, in a boost to the drugmaker’s ambitions for its medication to be a treatment option for more than half of lung cancer patients...
...As Emblaveo is a combination of two existing antibiotic treatments, aztreonam and avibactam, it would not qualify as a “priority” drug eligible for a voucher....
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...Merck has upped its profit and revenue guidance for this year as sales of its blockbuster cancer treatment Keytruda continue to surge....
...Leqembi, Biogen’s new Alzheimer’s drug, brought in $19mn in sales in the three months to the end of March, falling below analyst consensus estimates of $30mn as the rollout of the drug faltered....
...The US Food and Drug Administration says there is a shortage of Novo Nordisk’s and Eli Lilly’s diabetes drugs, while Belgium has banned the off-label use of Novo Nordisk’s diabetes drug for obesity treatments...
...AstraZeneca beat analysts’ estimates with 19 per cent growth in revenue in the first quarter of 2024, driven by stronger sales of its cancer drugs....
...A record 4,907 deaths in Britain were linked to illicit drugs in 2022, the latest year for which official data is available....
...Eli Lilly said that it plans to submit the results to the US Food and Drug Administration and other medicine regulators worldwide to seek approval for tirzepatide as a sleep apnoea treatment beginning this...
...Specification: Forensic psychology Click the link below to read the and then answer the questions: Violence in Argentina’s drug capital tests Javier Milei’s small-state vision Suggest how biological...
...“We are looking at a new era where it’s possible to treat obesity in the same way it’s been possible to treat high blood pressure,” said Holst from his University of Copenhagen office....
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market....
International Edition